TCOYD SPONSOR HIGHLIGHT
Xeris Pharmaceuticals, Inc., the maker of Gvoke HypoPen®, is dedicated to unlocking the potential of glucagon. We believe that easier-to-use medicines can have a profound impact on the lives of patients and their families. That is why our first products to market are liquid glucagon, but that is just the beginning. We are also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue advancements that have the potential to change lives.
EVERYTHING YOU NEED TO KNOW ABOUT Gvoke HypoPen®
USING GVOKE TO MANAGE YOUR DIABETES: PRESENTED BY TCOYD FACULTY
EDUCATIONAL VIDEOS
EDUCATIONAL ARTICLES
“Expect the Unexpected When It Comes to Severe Hypoglycemia in T2D”
“Educate Your Inner Circle on Hypoglycemia: It Could Save Your Life!”
“Treating a Low: When to Consume Sugar & When to Use Glucagon”
“A Renaissance in Glucagon: Ready to Use, Ready to Have!”
“The New Normal: Glucagon Ready to Go”
“Traveling with Diabetes: 7 Tips to Know Before You Go”
FOLLOW GVOKE & XERIS
